Update on Celltrion Healthcare IPO
Celltrion Healthcare (CELLHZ KS) was initially expected to submit the IPO prospectus back in March. But it didn't do it because it was found to...
345 Views
The Week That Was in NorthAsia@Smartkarma - THAAD Deployment, Mobile Lineage, and Activism in Japan
KoreaScott Laprise/ ä¹å¤©č and Prasenjit K. Basu have provided great insights regarding the political turmoil surrounding North Korea. Scott makes it...
406 Views
EM Managers - Most Avoided Stocks
ā¢ The 830 stocks in the benchmark MSCI Emerging Market Index all represent legitimate investments for global EM active managers. Whilst publicly...
498 Views
The Disconnect Is Growing
Celltrion Inc (068270 KS) 's Inflectra, a biosimilar to Johnson & Johnson (JNJ US) 's Remicade, had little impact on the critical U.S. market...
706 Views
Alpha Generation from Share Buybacks in Korea (2017 YTD)
In this report, we have identifiedĀ 26 stocksĀ in the Korean stock market that have announced share buyback programs so farĀ in 2017. These stocks...
1.4k Views